DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
34	神経線維腫症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03826940 (ClinicalTrials.gov)	February 19, 2019	23/1/2019	From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1	Linking Inhibition From Molecular to Systems and Cognitive Levels: a Preclinical and Clinical Approach in Autism Spectrum Disorders and Neurofibromatosis.	Autism Spectrum Disorder;Neurofibromatosis 1	Drug: Lovastatin 60 MG;Drug: Placebos	University of Coimbra	NULL	Recruiting	16 Years	65 Years	All	30	N/A	Portugal

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03826940
(ClinicalTrials.gov)

February 19, 2019

23/1/2019

From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1

Linking Inhibition From Molecular to Systems and Cognitive Levels: a Preclinical and Clinical Approach in Autism Spectrum Disorders and Neurofibromatosis.

Autism Spectrum Disorder;Neurofibromatosis 1

Drug: Lovastatin 60 MG;Drug: Placebos

University of Coimbra

NULL

Recruiting

16 Years

65 Years

All

N/A

Portugal